Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.740
+0.040 (0.85%)
At close: Nov 18, 2025, 4:00 PM EST
4.740
0.00 (0.00%)
After-hours: Nov 18, 2025, 4:28 PM EST
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $11.18 million as of November 18, 2025.
Market Cap
11.18M
Enterprise Value
-2.84M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.74
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $11.18M, an increase of 3.58%. That is a compound annual growth rate of 3.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 11.08M | 98.52% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |